Introduction
Kaposi sarcoma (KS) is the most prevalent malignant tumor in acquired immuno deficiency syndrome (AIDS) patients, particularly in sub-Saharan Africa (Orem et al., 2004) . The g2-herpesvirus KS-associated herpesvirus (KSHV or HHV8) is the pathological agent of KS and of lymphoproliferative disorders in B cells (Jenner and Boshoff, 2002) . KSHV establishes persistent infection for the duration of the host's existence, with the virus exhibiting a restricted gene expression program that maintains the circularized viral DNA genome during cellular replication (Parravicini et al., 2000) . KS lesions are mainly composed of interweaving bands of vascularizing spindle cells that are of endothelial origin and frequently associated with infiltrating inflammatory cells (Boshoff et al., 1995) . Although most spindle cells harbor latent virus (Staskus et al., 1997) , KS-derived spindle cells rapidly undergo senescence in cell culture, and the few KS-derived cell lines, such as KSY1 or KSIMM, are highly altered in their karyotypes and do not contain virus (Lunardi-Iskandar et al., 1995; Flamand et al., 1996; Albini et al., 1997) . KSHV is unable to immortalize endothelial cells (ECs) in vitro. However, long-term latent infection of KSHV was observed after immortalization of dermal microvascular ECs with human papillomavirus E6/E7 proteins (E-DMVECs) (Moses et al., 1999) . Uninfected E-DMVECs grow as discrete monolayers of cobblestone phenotype are contact-inhibited, and enter senescence if not passaged after attaining confluence. Upon infection with KSHV, E-DMVECs develop a spindle cell phenotype, lose contact inhibition, form foci when cultured postconfluence and acquire the ability to form colonies in soft agar. The E-DMVEC system has thus been extremely useful for evaluating changes in the cellular transcriptome and proteome, ultimately leading to the identification of both known as well as novel oncogenes that are likely to be involved in KS tumorigenesis (Moses et al., 2002; McAllister et al., 2004; Raggo et al., 2005) .
A recent report showed that autocrine stimulation of the insulin-like growth factor I receptor (IGF-IR) by IGF-II is required for continued growth and protection against apoptosis of KS-derived KSIMM cells (Catrina et al., 2005) . IGFs are part of a complex system of growth factors, growth factor receptors, and IGF-binding proteins and deregulation of IGF action has been implicated in tumorigenesis in many cancers (LeRoith and Roberts, 2003) . Since KSIMM cells lack viral genomes, we were interested to determine whether the IGF system is involved in maintaining the transformed phenotype of ECs latently infected with KSHV. Here we demonstrate that the insulin receptor (IR), but not IGF-IR, is strongly induced by KSHV infection. Moreover, gene knockdown or pharmacological inhibition of IR prevented KSHV-mediated tumorigenesis whereas expression of IGF-IR was not required. The IR is homologous to the IGF-IR, both are members of the receptor tyrosine kinase (RTK) superfamily, and both can be activated by IGF-II (Sciacca et al., 1999) . Binding of ligands to the IGF-IR or the IR triggers a signal cascade that leads to a similar activation of downstream effector molecules that regulate cell growth and survival (Ottensmeyer et al., 2000) . Our data suggest that latently infected KS cells can grow independent of the IGF-IR, but require IR-dependent signaling for continued growth.
Results
Deregulation of the IGF pathway in latently infected E-DMVEC To examine whether latent infection by KSHV modulates the IGF pathway, we extracted the expression profiles for the transcripts encoding insulin, IGF-I and IGF-II, their respective receptors (IR, IGF-IR and IGF-IIR), and the six insulin-like growth factor binding proteins (IGFBPs) from whole-genome expression arrays (Affymetrix U133A and B). Four independently KSHV-infected E-DMVEC cultures were compared to their respective age-and passage-matched uninfected controls. IGF-IR was present but remained unchanged, whereas the two Affymetrix probe sets for the IGF-IIR were induced in two of the four comparisons. Of the two probe sets representing the IR, one was induced in two, while the other one was induced in all four comparisons (Figure 1a) .
To confirm the gene array results, we performed quantitative real-time reverse transcriptase-polymerase chain reaction (qPCR). There was no significant change in IGF-IR mRNA expression levels, while IR and IGF-IIR transcripts were strongly induced (Figure 1b) . IGF-I and IGF-II mRNA expression was barely measurable by qPCR, while insulin mRNA was undetectable; neither transcript changed upon KSHV infection. Protein levels for all three receptors in infected and uninfected E-DMVEC lysates, measured by Western blot analysis, were consistent with mRNA expression levels ( Figure 1c) .
To confirm our observations in EC-based culture systems that permit transient infection with KSHV, we examined IR expression in DMVEC immortalized with telomerase (TIME cells) (Lagunoff et al., 2002) and primary DMVEC (Ciufo et al., 2001) . IR-induction was observed in either cell system (Figure 1d ). Moreover, RNA extracted from a dermal KS tissue biopsy showed a significant increase in IR gene expression when compared to normal skin tissue (Figure 1d ). The consistent induction of IR mRNA in KSHV-infected primary DMVEC and TIME cells, as well as in KS tissue, underscores that our findings in E-DMVEC reflect a true feature of KS tumorigenesis.
IGF-IR is not a transforming factor in KSHV-induced tumorigenesis of E-DMVEC Although expression levels of the IGF-IR did not change upon KSHV-infection, it was still possible that the IGF-IR contributes to KSHV-driven tumorigenesis. To examine this possibility, we used small interfering RNA (siRNA) to knockdown IGF-IR mRNA and protein expression. Upon siRNA-treatment, mRNA levels were reduced by 80% and protein levels were also dramatically reduced ( Figure 2) ; however, IGF-IR siRNA treatment did not affect KSHV-mediated tumorigenesis as measured by postconfluent growth, formation of spindle cells and foci formation (Figure 2c ). Similar results were obtained with IGF-IR-specific polymorpholino antisense oligomers (Supplementary Figure 1) .
In an independent approach, we used the blocking antibody MAb 391 to inhibit IGF-IR function (Surmacz, 2003) , which has been shown to downregulate IGF-IR during chronic treatment (Hailey et al., 2002) . Inhibition of IGF-IR activation by MAb 391 was confirmed in IGF-IR-transfected NIH-3T3 cells (Figure 2d and e). Treatment of KSHV-infected E-DMVEC for 14 days with MAb 391 did not prevent postconfluent growth and the development of spindle cell-containing foci (Figure 2f ). Taken together with the siRNA data, these data rule out the IGF-IR for postconfluent growth of KSHV-infected E-DMVEC.
The IR is necessary for KSHV-induced tumorigenesis The IR is encoded by two splice variants that differ by 12 amino acids in the cytoplasmic C-terminus: IR-A, which lacks exon 11, and a full-length IR-B (Denley et al., 2004) . To determine if these isoforms are differentially induced by KSHV, we performed RT-PCR on two independently derived lines of E-DMVEC, either uninfected or latently infected with KSHV. IR-A and IR-B were expressed in both KSHV-infected and uninfected E-DMVEC; however, IR-A was more abundant (Figure 3a) . While increased levels of both isoforms were seen following KSHV infection, their ratio did not change. Thus, IR-A is the predominantly expressed isoform in KSHV-infected E-DMVEC as has been observed in other cancers (Denley et al., 2004) .
To examine whether IR is involved in KSHV-induced transformation of E-DMVEC, we employed a pool of siRNA molecules targeted against both isoforms of IR to reduce IR mRNA levels. Transfection of this pool into KSHV-infected E-DMVEC resulted in an approximately 85% reduction in mRNA levels as determined by qPCR (Figure 3b ). Protein levels were also reduced significantly, as shown by Western blot (Figure 3c ). To determine the effect of inhibiting IR protein expression on KSHV-mediated tumorigenesis, we performed gene silencing experiments as above. As shown in Figure 3d , spindle cell formation, postconfluent growth and foci formation was dramatically reduced in IR-siRNA treated cells compared to untreated cells. In contrast, control siRNA-treated cells were indistinguishable from untreated cells (not shown). Similar results were obtained when translation of IR-mRNA was blocked with PMO-AS (Supplementary Figure 1) . We conclude that expression of the IR is important for the postconfluent growth of KSHV-infected E-DMVEC.
Inhibiting IR signaling impedes KSHV-mediated spindle cell foci formation Upon ligand binding, RTKs autophosphorylate and activate prosurvival signaling cascades. To determine whether increased expression of IR correlated with increased activation, we analysed IR autophosphorylation. As shown in Figure 3e , KSHV-induced IR-expression correlated with increased phosphorylation. In contrast, IGF-IR phosphorylation remained below detection in both infected and uninfected E-DMVEC.
To examine whether signaling by the IR is required for KSHV-mediated postconfluent growth, we used the IR-specific inhibitor HNMPA-(AM 3 ) [hydroxy-2-naphthalenyl-methyl phosphonic acid trisacetoxymethyl ester] (Saperstein et al., 1989; Baltensperger et al., 1992) . Treatment with 25, 50 and 100 mM HNMPA-(AM 3 ) inhibited the development of spindle cell-containing foci ( Figure 4a ) over a period of 14 days. This seemed to be due to the specific elimination of KSHV-infected cells and outgrowth of uninfected cells since the major latency associated protein LANA-1 was expressed in approximately 70% of untreated cells, whereas only 8% of cell expressed LANA-1 in cells treated with 50 mM HNMPA-(AM 3 ) for 14 days (Figure 4b ). Alternatively, it is also conceivable that KSHV-genomes were lost from HNMPA-treated cultures as described for other endothelial cell lines (Grundhoff and Ganem, 2004) .
At 50 mM, the inhibition of postconfluent growth was not due to a general effect on cell viability, as shown by One of the characteristics of latently infected E-DMVEC is their ability to form colonies in soft agar (Moses et al., 1999) . Untreated KSHV-infected E-DMVEC formed colonies as expected, while inhibition by HNMPA-(AM 3 ) reduced colonies in a concentration-dependent manner (Figure 6a ). Taken together, these results suggest that IR-dependent signaling is not required for KSHV-independent cell proliferation prior to reaching confluency, but is essential for the KSHVdriven postconfluent growth. The IR could thereby be required either for maintaining the infection or as part of the KSHV-mediated cellular changes required for contact-independent growth.
Signaling by the IR promotes survival (Ottensmeyer et al., 2000; Sciacca et al., 2002) , which, when inhibited by HNMPA-(AM 3 ), could trigger apoptosis. Accordingly, HNMPA-(AM 3 )-treated cells were assayed for apoptosis using Annexin V-FITC staining. Both treated and untreated E-DMVEC showed no difference in apoptosis sensitivity (Figure 6b ) compared to the Figure 3 IR is necessary for KSHV-infected E-DMVEC tumorigenesis. (a) RT-PCR to determine expression of IR isoforms in two independent uninfected and KSHV-infected E-DMVEC cultures (1 and 2). PCR products were separated on a 2% agarose gel to identify the distinct 36-base-pair difference in length. (b) IR transcript levels measured by qPCR in KSHV-infected E-DMVEC treated with nonspecific Cy3-labeled control siRNA, a siRNA targeted against a random gene or a SMARTpool siRNA (Dharmacon) specifically designed against IR. (c) Western blot analysis of IR protein levels after siRNA treatment comparing Cy3 control siRNA and IR siRNA-treated samples. Reduced levels of CRT were due to variation in protein loading and unrelated to IR siRNA, which does not affect CRT expression (see Figure 2b ). (d) Representative phase-contrast images comparing KSHV-infected E-DMVEC either untreated or treated with IR siRNA. Control siRNA treated samples were indistinguishable from untreated and are not represented here. Note the reduced spindle cell and contact-independent foci formation upon siRNA treatment. (e) KSHV-infected and uninfected E-DMVEC lysates were immunoprecipitated with either IR or IGF-IR and assayed by Western blot to compare receptor levels (top panel) or to determine the phosphorylation state of IR and IGF-IR using the phosphotyrosine-specific antibody, PY-20 (bottom panel). apoptosis-inducing compound Staurosporine. This suggests that IR is not involved in preventing apoptosis of KSHV-infected E-DMVEC during foci formation.
IR signaling mediated by mitogen-activated protein kinases IR activation leads to activation of the Erk mitogenactivated protein kinase (MAPK) and phosphoinositol-3 kinase (PI3K) pathways (Leibiger et al., 2001) . We assessed the effect of KSHV infection on the activation of these pathways by determining the levels of phosphorylated Erk and Akt. As shown in Figure 7a , only Erk phosphorylation is significantly increased in KSHVinfected E-DMVEC. We then inhibited IR activation in KSHV infected E-DMVEC with HNMPA-(AM 3 ) to verify a potential link between Erk phosphorylation and IR activation. Treatment with HNMPA-(AM 3 ) was able to reduce the level of Erk phosphorylation (Figure 7b ). This suggests that the IR directly signals via MAPK.
Shc is an IR adaptor substrate that is activated upon phosphorylation of IR ultimately leading to the activation of the Ras/MAPK pathway and concomitant stimulation of mitgogenic signaling pathways (Virkamaki et al., 1999; Leibiger et al., 2001) . While insulin does stimulate Shc phosphorylation, other growth factor stimuli are stronger activators of this adaptor protein. This may suggest that IGF-II signaling is the major activator of IR phosphorylation, which would be in line with the predominance of the IR-A isoform, which has a higher affinity for IGF-II (Denley et al., 2003 (Denley et al., , 2004 .
Discussion
We report in this study that the IR is essential for KSHV-mediated postconfluent and contact-independent growth of immortalized DMVEC in vitro. Gene expression profiling identified the IR as being upregulated when comparing uninfected and KSHV-infected prevented the formation of tumor-like foci in vitro. In contrast, similar treatments targeting the IGF-IR had no effect. The latter finding is different from a recent report that demonstrated that autocrine stimulation of the IGF-IR by IGF-II was essential for growth and survival of the KS-derived cell line KSIMM (Catrina et al., 2005) . Although originally derived from KS tumors, KSIMM are negative for KSHV (Flamand et al., 1996) . In contrast to KS tissues, which are characterized by predominant expression of lymphatic EC markers, KS-derived cell lines are usually characterized by expression of mesenchymal non-EC markers, suggesting that they are primitive or poorly differentiated ECs. The individual contribution of KSIMM-like cells and KSHV-transformed ECs in KS development is not known. Within the tumor environment, it is possible that the IR contributes to tumorigenesis of ECs, whereas the IGF-IR is required for the continued growth of undifferentiated non-infected ECs.
Expression of both IGF-IR and IR has been demonstrated in KS tissue. IGF-IR was detected by immunohistochemistry in tumor spindle cells (Catrina et al., 2005) . Overexpression of the IR in KS tissue compared to normal skin was reported by Wang et al. (2004) in a comprehensive microarray study, and we have independently shown that IR gene expression is induced in KSHV-infected primary DMVEC, AIDS-KS tissue and TIME cells. Furthermore, we show that the upregulated IR is phosphorylated and we observed increased activation of the downstream Erk pathway, but not the PI3K pathway, in KSHV-infected cells. Since Erk-activation could be inhibited by HNMPA, our data further suggest that Erk activation in latently infected cells is largely due to activation of the IR. In addition, it has been shown that the Erk pathway is activated by KSHV during de novo infection to modulate initial gene cellular and viral expression (Sharma-Walia et al., 2005) . PI3K is also activated early in KSHV infection (Sharma-Walia et al., 2005) , while we did not see PI3K activation in latently infected cells since there was no change in AKT phosphorylation in KSHV infected E-DMVEC (Figure 7) . Figure 5 Inhibiting IR signaling does not affect cell viability in KSHV-infected E-DMVEC. In all experiments, KSHV-infected E-DMVEC were left untreated or treated with 25, 50 and 100 mM HNMPA-(AM 3 ) for 14 days. (a) ATP Cell viability assay cells were lysed and ATP was quantitatively determined using a luciferin bioluminescence assay. PBS was used as negative control to establish background levels. (b) Preconfluent cell proliferation. Cells were seeded at low density treated with HNMPA-(AM 3 ). Total cell counts were determined using a hemocytometer and compared to normal cell proliferation of uninfected E6/E7-transformed DMVEC. (c) Postconfluent cell proliferation. Uninfected or KSHV-infected E-DMVEC were seeded at high density and treated with HNMPA-(AM 3 ). Total cell numbers of KSHV-infected E-DMVEC, counted using a hemocytometer, are presented as a percentage of uninfected E-DMVEC total cell counts to determine differences based on any effect of HNMPA-(AM 3 ) treatment. '*' indicates significantly different as determined by two-sided t-test, with a ¼ 0.05.
The IR joins a growing list of host cell proteins essential for the transformed phenotype in ECs infected by KSHV in vitro (Moses et al., 2002; McAllister et al., 2004; Raggo et al., 2005) . It seems that multiple mechanisms are required to support the postconfluent growth of DMVEC. Yet, not every growth factor receptor or oncogene that is expressed or upregulated in KSHV-infected cells is necessary for KSHV-mediated transformation, exemplified by the IGF-IR, as well as by a number of other KSHV-induced transcripts previously shown to be dispensable for this process (Raggo et al., 2005) .
The IR is known to be involved in tumorigenesis, particularly the A isoform that predominates in KSHVinfected DMVEC. A preferential expression of the IR-A isoform has been shown in several types of cancers, Figure 6 Inhibiting IR activity prevents anchorage-independent growth of KSHV-infected E-DMVEC, but does not affect apoptosis. (a) Total cell lysate harvested from KSHV-infected and uninfected E-DMVEC blotted for total AKT, phospho-AKT, total Erk and phospho-Erk to ascertain which IR signaling pathways were activated. There was a 1.5-fold increase in phosphorylated Erk in KSHVinfected versus uninfected E-DMVEC, while there was no change in phospho-AKT levels. (b) KSHV-infected E-DMVEC were either left untreated or treated with 50 mM HNMPA-(AM 3 ) overnight in complete media. The next day, total cell lysates were harvested and blotted for total AKT, phospho-AKT, total Erk and phospho-Erk, to determine if direct inhibition of IR signaling affected MAPK phosphorylation. Calreticuling (CRT) was used as a loading control.
including lung, colon, breast, ovarian and thyroid cancer (reviewed in Denley et al., 2003) . Splicing of IR presumably alters the affinity of the receptor for its ligand. While both isoforms have a high affinity for insulin, IR-A has a higher affinity for IGF-II, which is able to displace insulin and activate predominantly mitogenic rather than typical metabolic signaling pathways. Whereas both ligands are provided by the tissue culture medium, neither ligand is expressed in KSHVinfected cells to appreciable levels thus ruling out an autocrine mechanism. In vivo, exogenous ligands could be provided in a paracrine fashion by KSIMM-like cells or by non-tumor cells, or by IGF-II or insulin present in the blood. Further studies will be required to clarify which of these ligands is present in KS tumors and whether the ligands are produced within the tumor.
In summary, the IR is required to support the contact-independent, postconfluent proliferation of KSHV-infected ECs, thus allowing the development of multilayered foci in monolayer culture, or colony growth in soft agar. Since these in vitro growth characteristics mimic early-stage tumorigenesis, we propose that IR contributes to KS tumor development.
Methods and materials
Viruses, cell culture and reagents KSHV-infected E-DMVEC were established and maintained as previously described (Moses et al., 1999) . KSHV-infected DMVEC were used in experiments when >90% of the cells expressed LANA-1. The infection rate was approximately 70% for the TIME cells and primary DMVEC (Lagunoff et al., 2002) . HNMPA-(AM 3 ) was obtained from EMD Biosciences (San Diego, CA, USA). Antibody aIGF-IR mAb 33255 (Cat no. MAb 391) was purchased from R&D Systems (Minneapolis, MN, USA). Polyclonal antibodies and IRb (C-19)) and monoclonal antibody antiphosphotyrosine (PY20) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse monoclonal anticalreticulin (SPA-601) was purchased from Stressgen, (Victoria, BC, Canada). Antibodies for phospho-Erk (no. 9101), Erk (no. 9102), phospho-Akt (no. 4058) and Akt (no. 9272) were obtained from Cell Signaling Technologies (Danvers, MA, USA).
Microarray experiments and analysis cDNA synthesis, hybridization to HG_U133A and B (Affymetrix) and signal intensity normalization were performed at the OHSU microarray core facility (www.ohsu.edu/gmsr/amc). GeneChip data were analysed with Arrayassist (Stratagene). Comparisons were made between passage-matched KSHV-infected E-DMVEC and mock-infected E-DMVEC in four separate experiments. A master data table consisting of expression values extracted from all CEL files was created with the Probe Logarithmic Error Intensity Estimate (PLIER) method. To define the baseline from which changes in gene expression data was determined in KSHV-infected samples, a virtual chip comprising all mock-infected control expression data were used. Significant changes with a P-value of 0.01 was determined by ANOVA with variance stabilization and no P-value correction.
RT-PCR qPCR was performed on an ABI7700 sequence detection system (Applied Biosystems, Foster City, CA, USA). Target gene expression was compared to the housekeeping gene GAPDH. Total RNA was purified from E-DMVEC, primary DMVEC and TIME cells using RNeasy spin columns (Qiagen Inc., Valencia, CA, USA). Human tissue was a generous gift from H Koon and BJ Dezube and prepared as previously described (Raggo et al., 2005) . Total RNA was treated with DNase I (DNase Free: Ambion, Austin, TX, USA) before synthesis of cDNA by random hexamers and Superscript III (Invitrogen, Carlsbad, CA, USA). The following primers were selected by using the software Primer Express (Applied Biosystems): IGF-II 854F: TT CCGGACAACTTCCCCAG, 919R: 5 0 TGGACTGC TTCCAGGTGTCA; IGF-I 318F: TTTCAACAAGCC CACAGGGT, 379R: 5 0 CCACGATGCCTGTCTGA GG; IGF-IIR 6333F: GCAGAAGCTGGGTGTCATA GG, 6420R: 5 0 CACGGAGGATGCGGTCTTAT; IGF-IR 2184F: GGAGGAGGCTGAATACCGC, 2252R: 5 0 TCAGGTCTGGGCACGAAGAT, IR 1103F: GGT CCCTGTCCCAAGGTGT, 1161R: 5 0 GTCACCGAGT CGATGGTCTTC. Reactions were performed using SYBR green PCR core reagents. Relative expression values between mock and uninfected, normal skin, and KS tissue were calculated by the comparative C t method (Livak and Schmittgen, 2001) . Dissociation curves were performed on human reference RNA after each amplification run to control for primer-dimers.
RT-PCR to determine IR isoforms was performed by standard approaches using the following primers: 2229F: 5 0 AACCAGAGTGAGTATGAGGAT; 2844R: 5 0 CCGTTCCAGAGCGAAGTGCTT.
Western blot analyses and immunoprecipitations
For immunoprecipitation, cells were washed twice with ice-cold phosphate-buffered saline (PBS), lysed in NP-40 buffer (1% NP-40, 150 mM NaCl, 10% glycerol, 20 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0), 0.2% SDS), containing protease inhibitors (Roche Diagnostics; Indianapolis, IN, USA), 1 mM NaVO 4 and 1 mg/ml pepstatin. Lysates were cleared and protein concentration was determined as above. For IGF-IR and IR, 500 mg of whole-cell lysate protein was immunoprecipitated with 10 mg of anti-IGF-IR or anti-IR antibody and incubated overnight at 41C while rocking. Protein A-agarose bead slurry (Upstate) (100 ml) was added for 2 h rocking at 41C. Three washes were performed and the pellet was boiled in 2 Â SDS sample buffer. The beads were spun down and the supernatant was separated by a 7% SDS-PAGE followed by transfer to nylon membranes. Blots were probed with antiphosphotyrosine, stripped in 5 Â stripping buffer (1 M Tris-Cl, pH 6.8; 10% SDS; 0.7% (v/v) b-mercaptoethanol), and reprobed with their respective antibodies. Bound antibodies were detected by enhanced chemiluminescence (Amersham), and film exposures were quantitated using a scanning densitometer (Bio-Rad).
siRNA treatments KSHV-infected E-DMVEC were seeded the day prior to siRNA treatment at 30% confluency in 35-mm polystyrene dishes (Corning). On the day of treatment, for each sample, 3 ml Oligofectamine (Invitrogen) was mixed with 12 ml OptiMEM (GIBCO-Invitrogen) for 5 min at room temperature. A mix of 200 nM siRNA and 180 ml OptiMEM were added to Oligofectamine mix and incubated 20 min at room temperature. Cells were washed once in OptiMEM and 800 ml OptiMEM was added to dish prior to adding 200 ml siRNA mix. Cells were incubated 6 h before receiving a second treatment of siRNA as before. Cells were incubated overnight and siRNA mix was removed and replenished with 2 ml complete media. siRNA-treated cells were incubated 4-6 days to determine peak of downmodulation at which point protein levels were assayed by Western Blot or mRNA expression by qRT-PCR. Dishes used for microscropy were washed twice in PBS and fixed in 3.7% paraformaldehyde for 20 min before washing again and adding a coverslip over 80 ml glycerol.
Focus inhibition assay KSHV-infected E-DMVEC were seeded 30-50% confluency on 35-mm dishes (Corning) and treated either with siRNA or the IR small-molecule inhibitor, HNMPA-(AM 3 ) for a 2-week period. Inhibitor was added during change of medium (every 3 days) whereas a second round of siRNA treatment was performed 7 days after the first treatment to maintain knockdown of specified genes. Cells were examined for spindle-cell formation, loss of contact inhibition, a result of adherent foci in the monolayer, or virus-induced cytopathic effect by microscopy.
Immunofluorescence microscopy Cells were washed twice with 1 Â PBS, and fixed with 3.7% formaldehyde (in PBS) for 20 min at room temp. Cells were washed twice with 1 Â PBS and permeabilized with 0.1% Triton X-100 (in PBS), for 5 min. Afterwards, cells were washed three times with 2% PBA (bovine serum albumin (BSA) in PBS). Primary rabbit polyclonal anti-LANA-1 (ORF73) (a gift from Dr Bala Chandran; Rosalind Franklin University, Chicago, IL, USA) was added at 1:500 for 2 h at 371C. Cells were washed three times with 2% PBA (BSA in PBS) and incubated with goat anti-rabbit 594 Alexa Fluor secondary (Molecular Probes, Eugene, OR, USA), 1:500 for 45 min at 371C. Images were analysed with a Nikon fluorescence microscope.
Cell viability assay
Cell viability was measured as protocol suggested in the ATP Determination Kit (Molecular Probes, Cat no. A-22066). KSHV-infected E-DMVEC treated with HNMPA-(AM 3 ) for 14 days in a 96-well plate were lysed in 1% Triton X-100 for 10 min. Five microliters of D-luciferin/luciferase mix were added per sample and immediately read in a luminometer.
Soft agar assay
Forty thousand KSHV-infected E-DMVEC treated with HNMPA-(AM 3 ) or left untreated for 14 days were plated in 1.5 ml endothelial-SFM growth medium supplemented with 10% human AB serum, 25 mg/ml EC growth supplement and 0.4% melted agarose onto a 3-ml bottom layer of 0.5% agarose medium per well of a six-well dish. The cells were fed several drops of medium every 3 days, and colonies were photographed after 2-3 weeks.
Annexin V-FITC apoptosis detection assay Apoptosis in KSHV-infected E-DMVEC was analysed with the R&D System Annexin V-FITC Apoptosis Detection kit (Cat no. TA4638). Cells were washed once in PBS and resuspended in serum-free medium, followed by treatment with Staurosporine (1 mM), HNMPA-(AM 3 ) (50 mM) or left untreated overnight. Cells were trypsinized and washed in 2% BSA in PBS before each sample was resuspended in 100 ml Annexin Reagent (10 ml 10Â binding buffer, 10 ml propidium iodide, 1 ml annexin V-FITC, and 79 ml ddH 2 O) for 15 min at room temperature. Four hundred microliters 1 Â binding buffer was added before samples were analysed by flow cytometry.
